Canada Grants C$7 Million to Greenland Molybdenum Mine to Strengthen Critical Minerals Supply 
Kakaku.com Shares Rise as Bain Capital and LY Corp Prepare Higher Takeover Bid Than EQT 
Open-Source AI Models Gain Ground as Enterprises Seek Lower-Cost Alternatives, Citi Says 
Asian Stocks End Strong Quarter as Dollar Surges, Yen Hits 40-Year Low Ahead of US Jobs Data 
Morgan Stanley Raises Tesla Q2 Delivery Forecast on Strong Europe and China Demand 
Oil Prices Slip as U.S.-Iran Peace Talks and Strait of Hormuz Risks Keep Markets on Edge 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
Trump Urges Gasoline Retailers to Cut Prices to $2.50 Per Gallon, Warns of Legal Action 
UBS Raises TSMC Price Target to T$3,400 on Strong AI Chip Demand Outlook 
Dollar Slips Ahead of Key U.S. Jobs Data as Fed Rate Outlook, ECB, and Iran Talks Shape Forex Markets 
Momenta Launches Hong Kong IPO to Raise Up to $751 Million for AI and Robotaxi Expansion 
Japan Targets 1%+ Real Economic Growth With ¥370 Trillion Investment Plan 
Central Banks Eye Gold, Reduce Dollar Exposure as AI Adoption Accelerates: OMFIF Survey 
Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings 
Baidu Shares Rally as Kunlunxin Eyes $50 Billion Hong Kong IPO 
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion 
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service 
SK C&C has signed a deal with Microsoft Korea for cooperation in the advancement of AI cerebral hemorrhage solutions. The former is planning to register its imaging solution on Microsoft Azure for its healthcare platform.
SK C&C said it inked the memorandum of understanding (MOU) with Microsoft Korea on Thursday, Feb. 2. It has partnered with the American tech firm so it can expand into the global market for digital healthcare solutions. The IT services unit of the SK Group is also aiming to strengthen the industry ecosystem through the deal.
As per The Korea Economic Daily, under the agreement, the Medical Insight Plus Cerebral Hemorrhage imaging medical solution that was developed by SK C&C will be filed under the Microsoft Azure Healthcare neuroradiology category which is the company's cloud platform that specializes in healthcare.
Once registered, medical clinics that would like to make use of the solution can simply buy it from the Azure Marketplace. Buyers will also be able to receive follow-up services on the platform. SK C&C will also jump into the global market by working with the in-country sales organization of Microsoft company.
"Starting with Asia and Oceania, we will actively seek out various solutions for the global healthcare market as well as customized digital IT service markets in the medical field," SK C&C's Healthcare Group's head, Yoon Dong Joon, said.
Korea Biomed Review stated that SK C&C's Medical Insight+ Brain Hemorrhage is an AI-based cerebral hemorrhage imaging solution that assesses brain CT scan images. The solution can complete the analysis within seconds. Thus, doctors are immediately informed about any bleeding or abnormalities detected. The company said that the accuracy of the software is more than 98%
SK C&C further stressed that the imaging solution software has the ability to identify even the smallest bleeding that can be missed by professional neuro-head and neck radiologists.
